AGEN

Agenus (AGEN)

About Agenus (AGEN)

Agenus, Inc. is a clinical-stage company, which engages in the development and commercialization of technologies to treat cancers and infectious diseases. Its product pipeline includes Balstilimab, Zalifrelimab, AGEN1181, AGEN1327, AGEN2373, AGENt-797 and AGEN1777. The company was founded by Garo H. Armen and Pramod K. Srivastava on March 31, 1994 and is headquartered in Lexington, MA.

Details

Daily high

$4.17

Daily low

$3.97

Price at open

52 Week High

$7.34

52 Week Low

$1.38

Market cap

138.1M

Dividend yield

0.00%

Volume

2,030

Avg. volume

491,958

P/E ratio

-1.91

Agenus News